Trials / Unknown
UnknownNCT05761717
Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation
Clinical Study of mRNA Personalized Tumor Vaccine Encoding Neonatal Antigen Combined With Sintilimab Injection Liver Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 67 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an open, one-arm study to evaluate the safety and efficacy of mRNA personalized tumor vaccine (tumor vaccine) encoding neonatal antigen in combination with Sintilimab injection for adjuvant prevention of postoperative recurrence of hepatocellular carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I njection | Subcutaneous Injection |
Timeline
- Start date
- 2023-04-20
- Primary completion
- 2025-03-12
- Completion
- 2025-06-12
- First posted
- 2023-03-09
- Last updated
- 2023-03-09
Source: ClinicalTrials.gov record NCT05761717. Inclusion in this directory is not an endorsement.